Eudaimonia Asset Management »

Arcutis Biotherapeutics shares owned by Eudaimonia Asset Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Eudaimonia Asset Management from 13F filings

Historical chart of Eudaimonia Asset Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Eudaimonia Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Eudaimonia Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.2M 214k 29.04
2025-03-31 $3.4M 216k 15.64

More positions owned by Eudaimonia Asset Management

Credo Technology Group Holding Common Stock (CRDO)
Advanced Energy Industries Common Stock (AEIS)
nLight Common Stock (LASR)
Fabrinet Common Stock (FN)
TTM Technologies Common Stock (TTMI)
Madrigal Pharmaceuticals Common Stock (MDGL)
Bridgebio Pharma Common Stock (BBIO)
Guardant Health Common Stock (GH)
Dycom Industries Common Stock (DY)
Sanmina Corp Common Stock (SANM)
Zurn Elkay Water Solutions Corp Common Stock (ZWS)
Hecla Mining Common Stock (HL)
Turning Point Brands Common Stock (TPB)
Blackrock Funds - Equities ETF (SMIN)
Protagonist Therapeutics Common Stock (PTGX)

View all positions for Eudaimonia Asset Management

Top funds holding Arcutis Biotherapeutics

Suvretta Capital Management
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Jennison Associates
Polar Capital Holdings
State Street Corporation
Gilder, Gagnon, Howe & Co
UBS Group
Geode Capital Management
Henderson Group
D. E. Shaw & Co
Ensign Peak Advisors
Franklin Resources

View all funds holding Arcutis Biotherapeutics